• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Beaumont Health Set to Acquire Summa Health


The arrangement will reportedly strengthen both organizations’ ability to improve the quality of care and the overall health of their communities.

Southfield, Michigan-based Beaumont Health and Akron, Ohio-based Summa Health have signed a definitive agreement to make Summa Health a subsidiary of Beaumont Health.

Beaumont Health is Michigan’s largest healthcare system with $4.7 billion in total annual net patient revenue and is most preferred for healthcare in Southeast Michigan, according to NRC Health survey data. Summa Health is one of the largest integrated healthcare delivery systems in Ohio with total annual revenues of $1.4 billion. 

The arrangement will reportedly strengthen both organizations’ ability to improve the quality of care and the overall health of their communities.

The two organizations signed a Letter of Intent in July 2019 and then began an extensive review of both organizations’ clinical, regulatory and financial systems. Signing the definitive agreement is the next step in the process of bringing Summa Health into the Beaumont Health family. The organizations are in the process of submitting the agreement to state and federal regulatory agencies for final approval and hope the transaction will close by the end of the first quarter of 2020. Together, the combined organization will have $6.1 billion in total revenue, 45,000 employees and more than 6,000 affiliated physicians.

“Conversations between leaders and staff at both organizations have been going well. We very much look forward to working even more closely together now that we have a definitive agreement in place,” Beaumont CEO John Fox said in a press release. “As we grow our presence in Summa’s market area, our significant investments in our Michigan employees and operations will continue and be further enabled.”

Related: Factors That Have Pushed Healthcare Forward in Last Decade

The newly combined organization will utilize the financial strength of both organizations to fund the health system’s overall plan, which includes significant capital and operating projects, to drive ongoing growth in Northeast Ohio and Michigan.

“We are excited to deliver on our shared mission to provide compassionate, quality care, and enhance the health of our communities,” said Summa Health president and CEO Cliff Deveny, MD. “Our Board is confident that this partnership will further our abilities to not only provide excellent clinical services throughout Northeast Ohio, but also position our leadership, physicians, and employees for continued success and growth.” 

Summa Health will retain a local Board to support the oversight of clinical operations in Ohio. SummaCare, Summa’s health insurance operation, will remain an integral part of Summa Health and the organizations will work together to identify opportunities to drive future expansion.

“Over the past few months, our team has spent a considerable amount of time with the Beaumont team,” Summa Health Board Chair Anthony Lockhart said. “We believe that by becoming part of the Beaumont family, we will be able to gain efficiencies from being part of a larger organization, further invest in delivering high-quality, patient centered care and improve local access to the services most needed by our patients and communities.”

Beaumont Board Chair John Lewis added, “The planned addition of Summa will allow us to serve more people and become a regional health care leader. The efficiencies from transactions of this nature enable us to directly support our medical personnel who provide care ultimately to benefit the patients we serve.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.